Loading lessons…
Loading lessons…
Curated lessons across 8 learning paths — from first concepts to trial summaries and practical protocols. Pick your level, follow the curriculum, and build real understanding.
Where are you starting?
Choose a learning path below or search the library. Progress saves in your browser.
Prefer timeline chaos? Peptide X Quiz · Literacy certify
Pick a track — progress rings update as you complete lessons.
6 lessons
6mTesamorelin is the only FDA-approved GHRH analog. It targets deep belly (visceral) fat in a specific population. Here's what the trials actually found, including the muscle question.
9mSermorelin is the short GHRH analog older clinic pages still treat as the gentle GH option. The literature is real. The nightly microgram charts are practice culture, not a modern phase 3 program.
9mTesamorelin is one of the few GHRH analogs with an FDA-labeled daily milligram figure. That number belongs to a specific product and indication. It does not automatically travel to an unlabeled vial.
9mTwo products share the CJC-1295 name. Learn what the Drug Affinity Complex changes, what the 2006 human studies actually measured, and why the no-DAC version has far less published evidence.
9mTesamorelin is an FDA-approved GHRH analog with clinical trials proving 15–20% visceral fat reduction. Here's the full science, dosing guide, and what the latest research reveals about its longevity applications.
8mDiscover Tesamorelin, the only FDA-approved GHRH peptide, specifically indicated for reducing visceral fat.
Also available at /blog for legacy links.